Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

NEXT STORY
Protech Home Medical to Participate at the Sidoti Spring Investor Conference on March 24-25
PREV STORY
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Versartis Presents Efficacy, Safety, Metabolic and Adherence Data for Somavaratan in Oral Session at the International Congress of Endocrinology

MENLO PARK, Calif., Sept. 02, 2016 (GLOBE NEWSWIRE) -- Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused ...

author_avatar
NASDAQ Market News

Relay Therapeutics Announces Pricing of Initial Public Offering

author_avatar
NASDAQ Market News

electroCore Receives FDA Clearance for gammaCore™ (nVNS) for Adjunctive Use for the Preventive Treatment of Cluster Headache in Adults

author_avatar
NASDAQ Market News